Q: I hold shares in Baxalta and am trying to decide what to do. I don't mind selling into the present market at a fair profit but I note shares are trading 10% under the terms of the offer from SHPG, I presume because few want to hold Shire stock, me included. Shire's price action over the last 18 months is pretty ugly and I show a P&F target much lower than here. Any opinion? Thanks, J.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Greetings 5i Team,
I have been patiently (no pun intended) waiting for this company to bounce back after all bumps it went through the past year. As things were looking good at the beginning of the year (due to positive year end results), it has taken another step back recently due to what's been happening to markets around the world. I was wondering if it's a good idea/time to dilute the price of my $0.95 cost/share now. Thank you for your time.
I have been patiently (no pun intended) waiting for this company to bounce back after all bumps it went through the past year. As things were looking good at the beginning of the year (due to positive year end results), it has taken another step back recently due to what's been happening to markets around the world. I was wondering if it's a good idea/time to dilute the price of my $0.95 cost/share now. Thank you for your time.
Q: Hi folks,can please get your analysis on Q results finally released by Nobilis,would u rate stock a buy,hold or sell. Thanks as always
Q: There seems to be 6 or more new buy ratings on this one despite the lack of earnings. Would you make a small speculative buy?
Thanks
Thanks
Q: Canadian bio stocks getting slaughtered today. CXR, CRH, MSL, PLI all down 7-9%. Concordia was down over 5% Friday and over 8% Thursday. Why has the market suddenly decided these stocks are not worth owning? What is your view on this sector? Concordia has just lost over 20% in just three days.
Q: Hi Peter.. I hold the above stocks and would like to lower my exposure to the sector due to the volatility, what would be the weakest link of the group? Thank you Anthony
Q: Further to Arnold's question today, would you be confident in adding to a position in RX now? I have held it for quite a while and also observed the flat price curve; and have been pondering sell or add.
As technicians look at the RX chart, would they be thinking a "breakout" to the upside as more likely than to the downside especially when coupled with the metrics you and Arnold mentioned?
And of course suggest buying more?
Thanks.
As technicians look at the RX chart, would they be thinking a "breakout" to the upside as more likely than to the downside especially when coupled with the metrics you and Arnold mentioned?
And of course suggest buying more?
Thanks.
Q: I purchased this company before joining 5i Research. It is turning out to be fraught with lots of problems, the most current being that they have received a letter from NYSE regulation stating that they are not in compliance due to the company's failure to timely file its 3Q report. If they don't respond by Feb. 5th the co. could be de-listed from the NYSE. So what to do with this stock at this stage? Hold or cut my losses?
Q: I know that you have a high regard for PLI. I am wondering if it could be a potential take-over target? I believe I read some time ago that one shareholder had a very large position which I assume could put a damper on take-over activity. Your advice is always so helpful.
Thank you,Peter
Thank you,Peter
Q: I am wondering why you think biosyent hasn't moved in the past six months, depute excellent growth in revenue and earnings, ROE above 40%, no debt, and new products coming on stream. Any thoughts?
Q: What do you think about the management changes announced today? Is it a sign of accounting manipulation of any sort?
Thanks
Thanks
Q: Happy New Year Peter and staff. Nobilis shareholders are involved in a law suit in U.S. Do you feel I should get out now or wait it out. There is no loss now but it can be so messy! Thanks your you expert insight. Rossana
Q: Hi folks,can u please comment on re-statement of financials for Nhc/t.Is this good or bad,and long term,is this stock a buy,hold or total avoid. Thanks as always
Q: Happy New Year to the 5i Team,
I found your answer to the question regarding PHM`s year end results to be clear, factual, but guarded; understandable, considering the dramatic start to this morning`s opening of the North American markets. By the end of the day, the stock went up 25% with huge volume. I am currently with BMO Investorline, who are on record as stating that ``There are currently no news headlines for this security`. Without overstating the obvious, would you be able to offer any further observations or feedback after today`s results, on an otherwise gloomy day? I find it hard to believe that there has not been more interest shown by other members in this event. Thank you as always. Rick
I found your answer to the question regarding PHM`s year end results to be clear, factual, but guarded; understandable, considering the dramatic start to this morning`s opening of the North American markets. By the end of the day, the stock went up 25% with huge volume. I am currently with BMO Investorline, who are on record as stating that ``There are currently no news headlines for this security`. Without overstating the obvious, would you be able to offer any further observations or feedback after today`s results, on an otherwise gloomy day? I find it hard to believe that there has not been more interest shown by other members in this event. Thank you as always. Rick
Q: Hi Guys,
Could you comment on PHM's stock based compensation for 2015 of $9,162,835.
Is this reasonable and what holds in the future for this?
Thanks
John
Could you comment on PHM's stock based compensation for 2015 of $9,162,835.
Is this reasonable and what holds in the future for this?
Thanks
John
Q: Happy New Year to all. Could have your opinion of the merger of agn and pfe. and a 1 year outlook for agn.
Q: Is Cipher a good deal at it's current price? Can you update us on your view of this company?
Q: Hello 5i!
Thinking of adding PHM at these low levels to my portfolio, what allocation is reasonable within a diversified portfolio, I am a long term investor, well diversified portfolio and can handle risk.
Thanks!
Thinking of adding PHM at these low levels to my portfolio, what allocation is reasonable within a diversified portfolio, I am a long term investor, well diversified portfolio and can handle risk.
Thanks!
Q: Could you please comment on $CRH for a medium term hold, thanks Valter
Q: Hi
My holdings in VRX are near my purchase price after the bounce back from the short attack. I'm concerned about headwinds from the issues around the short and wonder if it would make sense to switch to one of CXR, CRH or GUD.Thanks Keith
My holdings in VRX are near my purchase price after the bounce back from the short attack. I'm concerned about headwinds from the issues around the short and wonder if it would make sense to switch to one of CXR, CRH or GUD.Thanks Keith